Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging
Risks from imaging-related radiation exposure have become a popular topic in the media. Because these tests are commonly applied to patients at a cancer center, it is important to understand what patients know, how they feel about what they know, where they get their information, and how satisfied they are with available risk-benefit communication on this topic. The purpose of this study is to understand how cancer patients perceive risks and benefits of diagnostic radiation and their satisfaction with healthcare communication on this topic.
Checked against the public recordLast updated Jun 25, 2015 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Interventions being studied
- Behavioral: Focus Group Sessions; Behavioral: Focus Group Sessions; Behavioral: Focus Group Sessions; Behavioral: Focus Group Sessions; Behavioral: Focus Group Sessions; Behavioral: Focus Group Sessions
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * English-language fluent * 18 years of age, or older * Provide informed consent * Group 1: Patients undergoing chemotherapy for Stage IV colorectal carcinoma. * Group 2: Parents of pediatric patients who have undergone treatment for stage 1-3 neuroblastoma. * Group 3: Women who have undergone treatment for early stage breast cancer within the preceding 6 months. * Group 4: Men undergoing surveillance imaging after treatment for testicular cancer. * Group 5: Patients currently or previously enrolled in the MSKCC lung cancer screening program. * Group 6: Patients enrolled in or eligible for the thoracic survivorship program. Exclusion Criteria: * Participants who don't speak English
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Memorial Sloan Kettering Cancer CenterNew York, New York
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 25, 2015. Always confirm current availability with the study team.